Rajan Sharma

Stock Analyst at Goldman Sachs

(0.41)

# 3,983

Out of 4,749 analysts

4

Total ratings

33.33%

Success rate

-14.6%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General Biotechnology

Stocks Rated by Rajan Sharma

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	AZN AstraZeneca	Initiates: Buy	$97	$70.76	+37.08%	1	May 30, 2024
	GSK GSK	Initiates: Neutral	$47	$35.27	+33.26%	1	May 30, 2024
	IMCR Immunocore Holdings	Reiterates: Overweight	$79	$32.88	+140.27%	2	Jun 20, 2023

AstraZeneca

May 30, 2024

Initiates: Buy

Price Target: $97

Current: $70.76

Upside: +37.08%

GSK

May 30, 2024

Initiates: Neutral

Price Target: $47

Current: $35.27

Upside: +33.26%

Immunocore Holdings

Jun 20, 2023

Reiterates: Overweight

Price Target: $79

Current: $32.88

Upside: +140.27%